DASATINIB

UNII:	RBZ1571X5H
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₂H₂₆ClN₇O₂S.H₂O
Preferred Substance Name:	DASATINIB
InChIKey:	XHXFZZNHDVTMLI-UHFFFAOYSA-N
GSRS Full Record:	RBZ1571X5H i

863127-77-9
5-THIAZOLECARBOXAMIDE, N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)-2-METHYL-4-PYRIMIDINYL)AMINO)-, MONOHYDRATE
BMS-354825 HYDRATE
BMS-354825-03
DASATINIB HYDRATE
DASATINIB HYDRATE [JAN]
DASATINIB MONOHYDRATE
DASATINIB [EMA EPAR]
DASATINIB [JAN]
DASATINIB [ORANGE BOOK]
DASATINIB [USAN]
DASATINIB [VANDF]
Dasatinib
Dasatinib monohydrate [WHO-DD]
N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]thiazole-5-carboxamide hydrate
NSC-759877
SPRYCEL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DASATINIB

Synonyms and Mappings

Resources